Related Topics
Cell treatments could aid in the treatment of genetic diseases, myocardial infarction, and a variety of other illnesses. New cells can be transferred into patients for blood ailments, and diabetes may also be treated by organ donation or β-cells derived from the patient’s natural stem cells.
Unintentional DNA changes, such as those that predispose people to cancer, are one risk connected with gene-edited cells. Furthermore, the diversity of tissue types makes it impractical to simply transplant cells from one individual to another.
Cells that are suitable for anyone, or immunologically undetectable cells, have been developed, however they are also connected with an elevated risk of cancer. Over a decade ago, Docent and Clinical Geneticist Kirmo Wartiovaara’s research group set out to create cells that could avoid these issues. The group has now succeeded in generating cells that cannot grow on their own and so cannot become cancerous.
Almost all of our diseases are primarily caused by cellular malfunction. One medical hope is to use fresh healthy cells to combat tissue damage, illnesses, and aging. According to the experts, the findings bring us one step closer to safe and new cell therapies.
Sources:
Rocio Sartori-Maldonado et al. (2024). Thymidylate synthase disruption to limit cell proliferation in cell therapies, Molecular Therapy. DOI: 10.1016/j.ymthe.2024.06.014
https://phys.org/news/2024-07-scientists-cell-precludes-malignant-growth.html
AI Disclosure Statement:
The Chromoscience uses AI-assisted tools to support the preparation and editing of science articles. Content is reviewed by the editor for clarity and consistency with the cited research before publication. Readers are encouraged to consult the original scientific publications for complete findings, methods, and limitations.
